In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 31.35 above Global Innovative Platforms Inc. average.

Within Medical Equipment & Supplies industry Global Innovative Platforms Inc. booked the highest Quick Ratio than Global Innovative Platforms in the third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 40, from total ranking in the second quarter 2026 at 1975.

Explain Quick Ratio?
How much Cash & cash equivalents GIPL�s has?
What are GIPL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GIPL Quick Ratio	(Jun 30 2026) Q3	(Mar 31 2026) Q2	(Dec 31 2025) Q1	(Sep 30 2025) Q4	(Jun 30 2025) Q3
Y / Y Current Liabilities Change	-71.97 %	-28.12 %	-65.06 %	-65.06 %	-87.18 %
Y / Y Cash & cash equivalent Change	16.8 %	96.11 %	-	-	1970.3 %
Quick Ratio MRQ	31.35	142.3	1.53	1.53	7.52
GIPL's Total Ranking	# 40	# 1975	# 1810	# 657	# 104
Seq. Current Liabilities Change	238.74 %	-80.17 %	0 %	-58.27 %	768.75 %
Seq. Cash & cash equivalent Change	-25.38 %	1738.76 %	0 %	-91.49 %	25.28 %

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	#
Healthcare Sector	#
Overall Market	# 0

Quick Ratio Statistics
High	Average	Low
142.3	12.53	0
(Mar 31 2026)		(Dec 31 2023)

Financial Statements
Global Innovative Platforms's Current Liabilities	$ 0 Millions	Visit GIPL's Balance sheet
Global Innovative Platforms's Cash & cash equivalent	$ 0 Millions	Visit GIPL's Balance sheet
Source of GIPL's Sales		Visit GIPL's Sales by Geography

Cumulative Global Innovative Platforms's Quick Ratio

GIPL's Quick Ratio for the trailling 12 Months

GIPL Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-65.82 %	-81.4 %	-88.81 %	-90.71 %	-91.51 %
Y / Y Cash & cash equivalent TTM Growth	61.47 %	223.16 %	3746.73 %	3447.75 %	3169.57 %
Quick Ratio TTM	18.24	10.73	7.59	5.2	3.86
Total Ranking TTM	# 123	# 214	# 211	# 297	# 1594
Seq. Current Liabilities TTM Growth	-37.54 %	-1.66 %	-28.5 %	-22.18 %	-66 %
Seq. Cash & cash equivalent TTM Growth	6.14 %	38.97 %	4.52 %	4.73 %	112.43 %

Quick ratio ranking by company, industry and sector >> Back to GIPL Financial Strength Comparisons >> Go to Compare GIPL Quick Ratio to its Competitors

On the trailing twelve months basis GIPL Cash & cash equivalent increased by 16.8 % in Q3 2026 year on year, while Current Liabilities more than doubled to $0 millions, this led to increase in in Global Innovative Platforms's Quick Ratio to 18.24, above GIPL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry GIPL achieved the highest Quick Ratio. While Quick Ratio overall ranking has improved so far to 15, from total ranking during the twelve months ending second quarter 2026 at 17.

Explain Quick Ratio?
How much Cash & cash equivalents GIPL�s has?
What are GIPL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	#
Healthcare Sector	#
Within the Market	# 40

trailing twelve months Quick Ratio Statistics
High	Average	Low
18.24	2.64	0.01
(Jun 30 2026)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Utah Medical Products Inc	42.28	$ 87.528 Millions	$ 2.070 Millions
Microbot Medical Inc	34.10	$ 132.596 Millions	$ 3.888 Millions
Global Innovative Platforms Inc.	31.35	$ 0.244 Millions	$ 0.008 Millions
Anteris Technologies Global Corp	14.02	$ 257.385 Millions	$ 18.360 Millions
Heartflow Inc	13.95	$ 615.238 Millions	$ 44.088 Millions
Ceribell Inc	13.13	$ 225.898 Millions	$ 17.200 Millions
Perspective Therapeutics Inc	12.80	$ 467.708 Millions	$ 36.544 Millions
Lemaitre Vascular Inc	12.57	$ 376.240 Millions	$ 29.935 Millions
Mobia Medical Inc	12.24	$ 177.090 Millions	$ 14.472 Millions
Envveno Medical Corporation	11.39	$ 21.486 Millions	$ 1.887 Millions
Pulse Biosciences Inc	9.26	$ 101.620 Millions	$ 10.978 Millions
Orchestra Biomed Holdings Inc	8.16	$ 109.963 Millions	$ 13.471 Millions
Biolife Solutions Inc	8.11	$ 113.100 Millions	$ 13.947 Millions
Bone Biologics Corporation	7.87	$ 4.032 Millions	$ 0.512 Millions
Beyond Air Inc	7.68	$ 26.340 Millions	$ 3.428 Millions
Talkspace Inc	7.62	$ 90.998 Millions	$ 11.937 Millions
Safe Pro Group Inc	7.24	$ 10.231 Millions	$ 1.413 Millions
Delcath Systems Inc	7.22	$ 95.902 Millions	$ 13.279 Millions
Streamex Corp	7.16	$ 18.586 Millions	$ 2.595 Millions
Endra Life Sciences Inc	7.04	$ 5.540 Millions	$ 0.787 Millions
Iradimed Corporation	6.45	$ 59.080 Millions	$ 9.164 Millions
Orasure Technologies Inc	6.39	$ 160.582 Millions	$ 25.119 Millions

Date modified: 2026-08-17T07:20:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.